Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12606635 | Glypican-2-binding moieties, chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12606623 | DLL3 targeting chimeric antigen receptors and binding agents | 🖼🧊📄§ | 2026-04-21 | 2043-04-27 | 0 | 31 |
| 12606803 | Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells | 🖼🧊📄§ | 2026-04-21 | 2040-07-13 | 0 | 31 |
| 12606553 | Crystalline forms, compositions containing same, and methods of their use | 🖼🧊📄§ | 2026-04-21 | 2042-03-09 | 0 | 31 |
| 12605443 | SAR-CoV-2 DNA vaccine and method of administering thereof | 🖼🧊📄§ | 2026-04-21 | 2041-10-13 | 0 | 31 |
| 12605395 | Materials and methods for immunosuppressive tumor microenvironment-targeted cancer therapy | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605445 | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 🖼🧊📄§ | 2026-04-21 | 2044-01-12 | 0 | 31 |
| 12605399 | Compositions for CFTR MRNA therapy | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12605321 | Personal care compositions | 🖼🧊📄§ | 2026-04-21 | 2041-03-29 | 0 | 31 |
| 12606779 | Active agent-containing articles | 🖼🧊📄§ | 2026-04-21 | 2043-08-28 | 0 | 31 |
| 12605710 | Flow channel structure for removing foreign substance, method for removing foreign substance, and method for manufacturing lipid particles | 🖼🧊📄§ | 2026-04-21 | 2043-03-13 | 0 | 31 |
| 12605441 | Immunogenic trimers | 🖼🧊📄§ | 2026-04-21 | 2044-06-04 | 0 | 31 |
| 12605452 | Compounds that degrade kinases and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-06-03 | 0 | 31 |
| 12606875 | Fish Totivirus | 🖼🧊📄§ | 2026-04-21 | 2040-02-04 | 0 | 31 |
| 12606523 | Deuterated organic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-07-03 | 0 | 31 |
| 12605331 | Composition comprising iris-derived exosome as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2043-12-27 | 0 | 31 |
| 12605334 | Method of enhancing the efficacy and stability of ingredients in suspensions | 🖼🧊📄§ | 2026-04-21 | 2043-12-04 | 0 | 31 |
| 12605402 | Therapeutic uses of oxidizing hypotonic acid solutions | 🖼🧊📄§ | 2026-04-21 | 2040-07-02 | 0 | 31 |
| 12606709 | Method for increasing specific surface area of titanium phosphate plate-shaped particles, and powder containing plate-shaped particles derived from titanium phosphate | 🖼🧊📄§ | 2026-04-21 | 2040-05-15 | 0 | 31 |
| 12605239 | Enhancement of hydration and improvement in gut health through cloacal delivery of products | 🖼🧊📄§ | 2026-04-21 | 2041-07-29 | 0 | 31 |
| 12605365 | Losartan liquid formulations and methods of use | 🖼🧊📄§ | 2026-04-21 | 2042-12-05 | 0 | 31 |
| 12605366 | Telmisartan for the treatment of hypertension in dogs | 🖼🧊📄§ | 2026-04-21 | 2040-04-30 | 0 | 31 |
| 12605446 | PSMA-targeted immunotherapies for cancers | 🖼🧊📄§ | 2026-04-21 | 2041-08-20 | 0 | 31 |
| 12605367 | Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies | 🖼🧊📄§ | 2026-04-21 | 2040-09-15 | 0 | 31 |
| 12605414 | Discovery of novel Akkermansia muciniphila AK32 and application thereof for improving intestinal function | 🖼🧊📄§ | 2026-04-21 | 2041-05-07 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12605332 | Transdermal delivery formulations | 🖼🧊📄§ | 2026-04-21 | 2042-10-31 | 0 | 31 |
| 12606796 | Delivery of oncolytic viruses using dendritic cells | 🖼🧊📄§ | 2026-04-21 | 2040-05-07 | 0 | 31 |
| 12605343 | Method for producing microbubble-containing electrolyte solution and method for producing microbubble-containing solvent used for preparing microbubble-containing electrolyte solution | 🖼🧊📄§ | 2026-04-21 | 2040-08-24 | 0 | 31 |
| 12605411 | Phospholipid compositions for delivery of therapeutic compounds | 🖼🧊📄§ | 2026-04-21 | 2044-06-05 | 0 | 31 |
| 12605415 | Compositions and methods | 🖼🧊📄§ | 2026-04-21 | 2043-07-11 | 0 | 31 |
| 12605412 | Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments | 🖼🧊📄§ | 2026-04-21 | 2040-09-29 | 0 | 31 |
| 12605355 | HA-paclitaxel conjugate for treatment of mesothelioma | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606528 | Methods and materials for inhibiting NF-kB activity | 🖼🧊📄§ | 2026-04-21 | 2040-11-20 | 0 | 31 |
| 12605448 | Porous self-healing polymer matrix for encapsulation of active macromolecules and methods | 🖼🧊📄§ | 2026-04-21 | 2040-07-20 | 0 | 31 |
| 12605449 | Drug-clay mineral complex containing phospholipid and oral administration composition including same | 🖼🧊📄§ | 2026-04-21 | 2041-07-01 | 0 | 31 |
| 12606801 | Herpesvirus with modified glycoprotein H for propagation in a cell | 🖼🧊📄§ | 2026-04-21 | 2037-06-08 | 0 | 31 |
| 12606831 | Method for producing t cells modified by chimeric antigen receptor | 🖼🧊📄§ | 2026-04-21 | 2039-01-18 | 0 | 31 |
| 12606578 | Crystal form of spirocyclic amine aryl phosphorus oxide compound and preparation method therefor | 🖼🧊📄§ | 2026-04-21 | 2043-07-28 | 0 | 31 |
| 12599638 | Feed and composition comprising lactic acid bacteria and fatty acid | 🖼🧊📄§ | 2026-04-14 | 2041-09-21 | 0 | 31 |
| 12600783 | Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-02 | 0 | 31 |
| 12600724 | Indole alkaloid and preparation method and use thereof | 🖼🧊📄§ | 2026-04-14 | 2042-11-09 | 0 | 31 |
| 12600766 | Anti-TDP-43 binding molecules and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-05-22 | 0 | 31 |
| 12600779 | LAG-3-binding molecules and methods of use thereof | 🖼🧊📄§ | 2026-04-14 | 2043-11-21 | 0 | 31 |
| 12600973 | CpG ODN having immunoregulatory function and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-31 | 0 | 31 |
| 12600955 | Replication-competent recombinant herpes simplex virus type 1 (HSV-1) comprising deletions in the ICP6 and IR regions | 🖼🧊📄§ | 2026-04-14 | 2039-08-09 | 0 | 31 |
| 12600793 | Chimeric antigen receptors with MAGE-A4 specificity and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-07-24 | 0 | 31 |
| 12600757 | Peptides inhibiting gamma-c-cytokine activity and methods of use | 🖼🧊📄§ | 2026-04-14 | 2038-04-04 | 0 | 31 |
| 12600945 | Human Vγ9Vδ2T cell proliferation culture method and culture medium | 🖼🧊📄§ | 2026-04-14 | 2039-02-19 | 0 | 31 |
| 12599628 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions | 🖼🧊📄§ | 2026-04-14 | 2045-05-28 | 0 | 31 |